Michael K. Klebert
Impact in
- Virology top 5%
- HIV Research and Treatment
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions
Papers in
-
- HIV/AIDS drug development and treatment 3
- SARS-CoV-2 and COVID-19 Research 2
-
- Pharmacological Effects and Toxicity Studies 2
- Co-authors
- Alem Haile (2 shared papers)Charles W. Goss (1 shared paper)Jane A. O’Halloran (2 shared papers)Rachel M. Presti (3 shared papers)Elizaveta Kalaidina (1 shared paper)Iskra Pusic (1 shared paper)Wooseob Kim (2 shared papers)Ali H. Ellebedy (3 shared papers)
- Journals
- Journal of the Association of Nurses in AIDS Care (3 papers)Nature (1 paper)Nature Immunology (1 paper)The Journal of Clinical Pharmacology (1 paper)The Journal of Immunology (1 paper)
- Partner nations
- United StatesNorwayNetherlands
In The Last Decade
Michael K. Klebert
9 papers receiving 553 citations
Michael K. Klebert's Hit Papers
Peers
Comparison fields: 5 of 72
- Virology 112
- Infectious Diseases 409
- Modeling and Simulation 41
- Emergency Medicine 52
- Immunology 90
Countries citing papers authored by Michael K. Klebert
This map shows the geographic impact of Michael K. Klebert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael K. Klebert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael K. Klebert more than expected).
Fields of papers citing papers by Michael K. Klebert
This network shows the impact of papers produced by Michael K. Klebert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael K. Klebert. The network helps show where Michael K. Klebert may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael K. Klebert, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans Hit paper breakdown → | 2021 | 309 |
| 2 | 1999 | 138 | |
| 3 | 2004 | 41 | |
| 4 | 2011 | 41 | |
| 5 | 2009 | 13 | |
| 6 | 2024 | 11 | |
| 7 | 2015 | 10 | |
| 8 | 2010 | 7 | |
| 9 | 2014 | 6 | |
| 10 | 2023 | 0 |
About Michael K. Klebert
Michael K. Klebert is a scholar working on Infectious Diseases, Pediatrics, Perinatology and Child Health, Epidemiology, Dermatology and Virology, having authored 10 papers that have together received 576 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (3 papers), Pharmacological Effects and Toxicity Studies (2 papers), SARS-CoV-2 and COVID-19 Research (2 papers), Dermatological and COVID-19 studies (1 paper), Pneumocystis jirovecii pneumonia detection and treatment (1 paper), Pharmaceutical Practices and Patient Outcomes (1 paper), Plant Pathogens and Fungal Diseases (1 paper) and Diabetes and associated disorders (1 paper). The work is most often cited by research in Virology (112 citations), Infectious Diseases (409 citations), Modeling and Simulation (41 citations), Emergency Medicine (52 citations) and Immunology (90 citations). Michael K. Klebert has collaborated with scholars based in United States, Norway and Netherlands. Frequent co-authors include Alem Haile, Charles W. Goss, Jane A. O’Halloran, Rachel M. Presti, Elizaveta Kalaidina, Iskra Pusic, Wooseob Kim, Ali H. Ellebedy, Lena Hansen and Aaron J. Schmitz. Their work appears in journals such as Journal of the Association of Nurses in AIDS Care, Nature, Nature Immunology, The Journal of Clinical Pharmacology and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.